Expert guidance on the management and challenges of long-COVID syndrome: a systematic review

References

• Kim SY, Aö Y. Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 Dashboard. Life Cycle [Internet]. 2022 [cited 2022];2:e10. DOI:10.54724/lc.2022.e10.
   Google Scholar
• Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428–442. Cited: in:: PMID: 34265229.
   PubMed Web of Science ®Google Scholar
• Crook H, Raza S, Nowell J, et al. Long covid—mechanisms, risk factors, and management. BMJ. 2021 [cited 2022 Apr 21];n1648. DOI:10.1136/bmj.n1648.
   PubMedGoogle Scholar
• Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. DOI:10.1016/j.socscimed.2020.113426. Cited: in:: PMID: 33199035.
   PubMed Web of Science ®Google Scholar
• Garner P. For 7 weeks I have been through a roller coaster of ill health, extreme emotions, and utter exhaustion. [Internet]. BMJ opinion; 2020. Available from: https://blogs.bmj.com/bmj/2020/05/05/paul-garner-people-who-have-a-more-protracted-illness-need-help-to-understand-and-cope-with-the-constantly-shifting-bizarre-symptoms/.
   Google Scholar
• Perego E, Callard F, Stras L, et al. Why the Patient-Made Term “Long Covid” is needed. Wellcome Open Res. 2020;5:224. Internet]. DOI:10.12688/wellcomeopenres.16307.1
   Google Scholar
• National Guideline Centre. Chronic asthma management. Available from: https://www.nice.org.uk/guidance/ng80/evidence/full-guideline-chronic-asthma-management-pdf-4656179345
   Google Scholar
• Long COVID or Post-COVID Conditions. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.
   Google Scholar
• WHO. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
   Google Scholar
• Healey Q, Sheikh A, Daines L, et al. Symptoms and signs of long COVID: a rapid review and meta-analysis. J Glob Health. 2022;12:05014. DOI:10.7189/jogh.12.05014. Cited: in:: PMID: 35596571.
   PubMed Web of Science ®Google Scholar
• Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. DOI:10.1136/bmj.m4938. Cited: in:: PMID: 33361141.
   PubMedGoogle Scholar
• Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. Cited: in:: PMID: 33453162.
   PubMed Web of Science ®Google Scholar
• Daher A, Balfanz P, Cornelissen C, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197. DOI:10.1016/j.rmed.2020.106197. Cited: in:: PMID: 33120193.
   PubMed Web of Science ®Google Scholar
• Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the covid symptoms study app [Internet]. Infectious Diseases (except HIV/AIDS); 2020 [cited 2022 Jun 14]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.10.19.20214494.
   Google Scholar
• Burn E, Tebé C, Fernandez-Bertolin S, et al. The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun. 2021;12(1):777. Cited: in:: PMID: 33536436.
   PubMed Web of Science ®Google Scholar
• Office for national statistics. https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.
   Google Scholar
• Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399–401.
   PubMed Web of Science ®Google Scholar
• Cirulli ET, Schiabor Barrett KM, Riffle S, et al. Long-term COVID-19 symptoms in a large unselected population [Internet]. Infectious Diseases (except HIV/AIDS); 2020. [cited 2022 Jun 14]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.10.07.20208702.
   Google Scholar
• Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. Cited: in:: PMID: 33306721.
   PubMed Web of Science ®Google Scholar
• Cellai M, O’Keefe JB. Characterization of Prolonged COVID-19 Symptoms in an Outpatient Telemedicine Clinic. Open Forum Infect Dis [Internet]. 2020;7(10):ofaa420.
   PubMed Web of Science ®Google Scholar
• Galal I, Hussein AARM, Amin MT, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021 cited 2022 Jun 14;15(10). doi: 10.1186/s43168-020-00049-4
   Google Scholar
• Wiech M, Chroscicki P, Swatler J, et al. Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front Immunol. 2022;13:886431. Cited: in:: PMID: 35757700. DOI:10.3389/fimmu.2022.886431
   PubMed Web of Science ®Google Scholar
• Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. DOI:10.3389/fmicb.2021.698169
   PubMed Web of Science ®Google Scholar
• Ferrandi PJ, Alway SE, Mohamed JS. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol [Internet]. 2020;129(4):864–867.
   PubMed Web of Science ®Google Scholar
• Jin M, Tong Q. Rhabdomyolysis as Potential Late Complication Associated with COVID-19. Emerg Infect Dis [Internet]. 2020;26(7):1618–1620.
   PubMed Web of Science ®Google Scholar
• Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (B Aires) [Internet]. 2021;57(5):418.
   PubMedGoogle Scholar
• Tomasoni D, Bai F, Castoldi R, et al. Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy. J Med Virol. 2021;93(2):1175–1179. Cited: in:: PMID: 32841387.
   PubMed Web of Science ®Google Scholar
• Nurek M, Rayner C, Freyer A, et al. Delphi panellists. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract. 2021;71(712):e815–e825. Cited: in:: PMID: 34607799.
   PubMed Web of Science ®Google Scholar
• WHO Clinical management of COVID-19. https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-2022.2.
   Google Scholar
• Funke-Chambour M, Bridevaux P-O, Clarenbach CF, et al. Swiss COVID Lung Study Group and the Swiss Society of Pulmonology. Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID. Respiration. 2021;100(8):826–841. Cited: in:: PMID: 34091456.
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. Cited: in:: PMID: 25554246.
   PubMed Web of Science ®Google Scholar
• D’Cruz RF, Waller MD, Perrin F, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7(1):00655–02020. Cited: in:: PMID: 33575312.
   PubMedGoogle Scholar
• Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomed Health Behav [Internet]. 2020;8:61–69. DOI10.1080/21641846.2020.1778227.
   Web of Science ®Google Scholar
• Guedj E, Million M, Dudouet P, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging [Internet]. 2021;48(2):592–595.
   PubMed Web of Science ®Google Scholar
• Morgul E, Bener A, Atak M, et al. COVID-19 pandemic and psychological fatigue in Turkey. Int J Soc Psychiatry [Internet]. 2021;67(2):128–135.
   PubMed Web of Science ®Google Scholar
• Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. Internet]. 2020;395(10227):912–920.
   PubMed Web of Science ®Google Scholar
• Dijkstra U, Gabreëls F, Joosten E, et al. Friedreich’s ataxia: intravenous pyruvate load to demonstrate a defect in pyruvate metabolism. Neurology. 1984;34(11):1493–1497. Cited: in:: PMID: 6493499.
   PubMed Web of Science ®Google Scholar
• Desagher S, Glowinski J, Prémont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci. 1997;17(23):9060–9067. Cited: in:: PMID: 9364052.
   PubMed Web of Science ®Google Scholar
• Fukushima M, Lee SM, Moro N, et al. Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury. J Neurotrauma. 2009;26(7):1095–1110. Cited: in:: PMID: 19594384.
   PubMed Web of Science ®Google Scholar
• Wang XF, Cynader MS. Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci. 2001;21(10):3322–3331. Cited: in:: PMID: 11331361.
   PubMed Web of Science ®Google Scholar
• Koivisto H, Leinonen H, Puurula M, et al. Chronic pyruvate supplementation increases exploratory activity and brain energy reserves in young and middle-aged mice. Front Aging Neurosci. 2016;8:41. Cited: in:: PMID: 27014054. DOI:10.3389/fnagi.2016.00041
   PubMed Web of Science ®Google Scholar
• Fink MP. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer’s ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care. 2002;5(2):167–174. Cited: in:: PMID: 11844984.
   PubMed Web of Science ®Google Scholar
• Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–260. Cited: in:: PMID: 18046878.
   PubMed Web of Science ®Google Scholar
• Abusalamah H, Reel JM, Lupfer CR. Pyruvate affects inflammatory responses of macrophages during influenza A virus infection. Virus Res. 2020;286:198088. DOI:10.1016/j.virusres.2020.198088. Cited: in:: PMID: 32634445.
   PubMed Web of Science ®Google Scholar
• Sheridan J, Kern E, Martin A, et al. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections. Antiviral Res. 1997;36(3):157–166. Cited: in:: PMID: 9477116.
   PubMed Web of Science ®Google Scholar
• Lupfer CR, Nadler R, Amen R, Martin A. Inhalation of Sodium Pyruvate to Reduce the Symptoms and Severity of Respiratory Diseases Including COVID-19, Long COVID, and Pulmonary Fibrosis. Eur J Respir Med [Internet]. 2021;3. doi:10.31488/EJRM.121
   Google Scholar
• Mitrani MI, Bellio MA, Sagel A, et al. Case report: administration of amniotic fluid-derived nanoparticles in three severely ill COVID-19 Patients. Front Med (Lausanne). 2021;8:583842. Cited: in:: PMID: 33816515. DOI:10.3389/fmed.2021.583842
   PubMed Web of Science ®Google Scholar
• Elneil S, Lalezari JP, Pourhassan NZ. Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab. J Transl Autoimmun. 2021;4:100097. DOI:10.1016/j.jtauto.2021.100097. Cited: in:: PMID: 33778462.
   PubMedGoogle Scholar
• Burge DJ, Eisenman J, Byrnes-Blake K, et al. Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. Lupus. 2017;26(8):825–834. Cited: in:: PMID: 27852935.
   PubMed Web of Science ®Google Scholar
• Crippa JAS, Pacheco JC, Zuardi AW, et al. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis Cannabinoid Res. 2021;7(5):658–669. Cited: in:: PMID: 34619044.
   PubMedGoogle Scholar
• Nguyen Y, Guillevin L. Eosinophilic granulomatosis with polyangiitis (churg-Strauss). Semin Respir Crit Care Med. 2018;39(4):471–481. Cited: in:: PMID: 30404114.
   PubMed Web of Science ®Google Scholar
• Martin SJ, McAnally HB, Okediji P, et al. Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study. Pain Manag. 2022;12(6):699–709. Cited: in:: PMID: 35289682.
   PubMed Web of Science ®Google Scholar
• Pitt B, Tate AM, Gluck D, et al. Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2022;8(4):402–405. Cited: in:: PMID: 35179184.
   PubMed Web of Science ®Google Scholar
• Covarrubias AJ, Perrone R, Grozio A, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–141.
   PubMed Web of Science ®Google Scholar
• Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (Nicotinamide Riboside Chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. Cited: in:: PMID: 31278280.
   PubMedGoogle Scholar
• Wirth KJ, Scheibenbogen C. Dyspnea in post-COVID syndrome following mild acute COVID-19 infections: potential causes and consequences for a therapeutic approach. Medicina (Kaunas). 2022;58(3):419. Cited: in:: PMID: 35334595.
   PubMed Web of Science ®Google Scholar
• Peña-Villalobos I, Casanova-Maldonado I, Lois P, et al. Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of wj-MSCs in diabetic mice. Front Physiol. 2018;9:995. DOI:10.3389/fphys.2018.00995. Cited: in:: PMID: 30104981.
   PubMed Web of Science ®Google Scholar
• Cabigas BP, Su J, Hutchins W, et al. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res. 2006;72(1):143–151. Cited: in:: PMID: 16930572.
   PubMed Web of Science ®Google Scholar
• Hadanny A, Rittblat M, Bitterman M, et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients - a retrospective analysis. Restor Neurol Neurosci. 2020;38(1):93–107. Cited: in:: PMID: 31985478.
   PubMed Web of Science ®Google Scholar
• Green FHY, Leigh R, Fadayomi M, et al. A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers. Trials. 2016;17(1):361. Cited: in:: PMID: 27464582.
   PubMed Web of Science ®Google Scholar
• May BC, Gallivan KH. Levocetirizine and montelukast in the COVID-19 treatment paradigm. Int Immunopharmacol. 2022;103:108412. DOI:10.1016/j.intimp.2021.108412. Cited: in:: PMID: 34942461.
   PubMed Web of Science ®Google Scholar
• Khan AR, Misdary C, Yegya-Raman N, et al. Montelukast in hospitalized patients diagnosed with COVID-19. J Asthma. 2022;59(4):780–786. Cited: in:: PMID: 33577360.
   PubMed Web of Science ®Google Scholar
• Najafloo R, Majidi J, Asghari A, et al. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021;12(20):3795–3805. Cited: in:: PMID: 34609841.
   PubMed Web of Science ®Google Scholar
• Boglione L, Meli G, Poletti F, et al. Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? Qjm. 2022;114(12):865–871. Cited: in:: PMID: 34850210.
   PubMed Web of Science ®Google Scholar
• Patocka J, Kuca K, Oleksak P, et al. Rapamycin: Drug Repurposing in SARS-CoV-2 Infection. Pharmaceuticals (Basel). 2021;14(3):217. Cited: in:: PMID: 33807743.
   PubMedGoogle Scholar
• Sifuentes-Franco S, Sánchez-Macías DC, Carrillo-Ibarra S, et al. Antioxidant and anti-inflammatory effects of Coenzyme Q10 supplementation on infectious diseases. Healthcare (Basel). 2022;10(3):487. Cited: in:: PMID: 35326965.
   PubMedGoogle Scholar
• Clavario P, De Marzo V, Lotti R, et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol. 2021;340:113–118. Cited: in:: PMID: 34311011. DOI:10.1016/j.ijcard.2021.07.033
   PubMed Web of Science ®Google Scholar
• Lerum TV, Aaløkken TM, Brønstad E, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021;57(4):2003448. Cited: in:: PMID: 33303540.
   PubMed Web of Science ®Google Scholar
• Bellan M, Soddu D, Balbo PE, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Network Open. 2021;4:e2036142. Cited: in:: PMID: 33502487. DOI:10.1001/jamanetworkopen.2020.36142
   PubMed Web of Science ®Google Scholar
• Spruit MA, Singh SJ, Garvey C, et al. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–e64.
   PubMed Web of Science ®Google Scholar
• Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand pulmonary rehabilitation guidelines. Respirology. 2017;22(4):800–819. Cited: in:: PMID: 28339144.
   PubMed Web of Science ®Google Scholar
• Rochester CL, Vogiatzis I, Holland AE, et al. An official American thoracic society/European respiratory society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373–1386. Cited: in:: PMID: 26623686.
   PubMed Web of Science ®Google Scholar
• WHO. WHO coronavirus disease (COVID-19) Dashboard. Available from https://covid19.who.int/
   Google Scholar
• Rehabilitation Considerations for the COVID-19 Outbreak. 2020. https://iris.paho.org/bitstream/handle/10665.2/52035/NMHMHCOVID19200010_eng.pdf?sequence=6&isAllowed=y
   Google Scholar
• Yelin D, Moschopoulos CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):S1198-743X(22)00092–1. Cited: in:: PMID: 35182760.
   Web of Science ®Google Scholar
• Reina-Gutiérrez S, Torres-Costoso A, Martínez-Vizcaíno V, et al. Effectiveness of pulmonary rehabilitation in interstitial lung disease, including coronavirus diseases: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2021;102(10):1989–1997.e3. Cited: in:: PMID: 33932361.
   PubMed Web of Science ®Google Scholar
• Besnier F, Bérubé B, Malo J, et al. Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue: The COVID-Rehab Study. Int J Environ Res Public Health. 2022;19(7):4133. Cited: in:: PMID: 35409815.
   PubMed Web of Science ®Google Scholar
• Bannister BA. Post-infectious disease syndrome. Postgrad Med J. 1988;64(753):559–567.
   PubMed Web of Science ®Google Scholar
• Rebman AW, Aucott JN. Post-treatment lyme disease as a model for persistent symptoms in lyme disease. Front Med. 2020;7:57. DOI:10.3389/fmed.2020.00057
   Web of Science ®Google Scholar
• Interim guidance on long-COVID management principles. Available from: https://www.iss.it/documents/20126/0/Rapporto+ISS+COVID-19+n.15_2021_EN.pdf/dd962ad9-fa53-73dd-7759-55cb5c167675?t=1627575304593
   Google Scholar
• Posada J, Valadkhan S, Burge D, et al. Improvement of severe fatigue following nuclease therapy in patients with primary sjögren’s syndrome: a randomized clinical trial. Arthritis Rheumatol. 2021;73(1):143–150. Cited: in:: PMID: 32798283.
   PubMed Web of Science ®Google Scholar
• Bozek A, Winterstein J. Montelukast’s ability to fight COVID-19 infection. J Asthma. 2021;58(10):1348–1349. Cited: in:: PMID: 32586154.
   PubMed Web of Science ®Google Scholar
• Kaplon H, Reichert JM. Antibodies to watch in 2021. MAbs. 2021;13(1):1860476. Cited: in:: PMID: 33459118.
   PubMed Web of Science ®Google Scholar
• De Maio A, Hightower LE. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress Chaperones. 2020;25(5):717–720. Cited: in:: PMID: 32424591.
   PubMed Web of Science ®Google Scholar
• El Mays TY, Choudhury P, Leigh R, et al. Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma. Respir Res. 2014;15(1):98. Cited: in:: PMID: 25355286.
   PubMedGoogle Scholar